dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Partridge, Ann H. |
dc.contributor.author | Niman, Samuel M. |
dc.contributor.author | Ruggeri, Monica |
dc.contributor.author | Peccatori, Fedro A. |
dc.contributor.author | Azim Jr., Hatem A. |
dc.contributor.author | Colleoni, Marco |
dc.contributor.author | Saura Manich, Cristina |
dc.date.accessioned | 2022-04-22T12:53:10Z |
dc.date.available | 2022-04-22T12:53:10Z |
dc.date.issued | 2021-10 |
dc.identifier.citation | Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, et al. Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy. Breast. 2021 Oct;59:327–38. |
dc.identifier.issn | 0960-9776 |
dc.identifier.uri | https://hdl.handle.net/11351/7371 |
dc.description | Càncer de mama; Desig d'embaràs; Dones joves |
dc.description.sponsorship | The POSITIVE trial and this work are sponsored by the IBCSG in non-North American countries and by the Alliance for Clinical Trials in Oncology in North America, with collaboration of the Breast International Group (BIG) cooperative groups and US National Clinical Trials Network groups. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | The Breast;59 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Hormonoteràpia |
dc.subject | Embaràs |
dc.subject | Mama - Càncer |
dc.subject.mesh | Cancer Survivors |
dc.subject.mesh | Hormones |
dc.subject.mesh | /therapeutic use |
dc.subject.mesh | Pregnancy |
dc.title | Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.breast.2021.07.021 |
dc.subject.decs | supervivientes de cáncer |
dc.subject.decs | hormonas |
dc.subject.decs | /uso terapéutico |
dc.subject.decs | embarazo |
dc.relation.publishversion | https://doi.org/10.1016/j.breast.2021.07.021 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Partridge AH] Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. [Niman SM] International Breast Cancer Study Group Statistical Center, Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA. [Ruggeri M] International Breast Cancer Study Group, Program for Young Patients, Coordinating Center, Bern, 3008, Switzerland. [Peccatori FA] Fertility and Procreation Unit, Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan, 20141, Italy. [Azim HA] Breast Cancer Center, Hospital Zambrano Hellion, School of Medicine, Tecnologico de Monterrey, San Pedro Garza Garcia, 66278, Mexico. [Colleoni M] International Breast Cancer Study Group, Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy. [Saura C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 34390999 |
dc.identifier.wos | 000696705600040 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |